Morgan Stanley’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-128,855
Closed -$7.67M 6916
2019
Q3
$7.67M Sell
128,855
-35,445
-22% -$1.9M ﹤0.01% 2398
2019
Q2
$7.69M Buy
164,300
+7,452
+5% +$313K ﹤0.01% 2448
2019
Q1
$6.09M Buy
156,848
+80,911
+107% +$3.31M ﹤0.01% 2527
2018
Q4
$2.87M Sell
75,937
-12,057
-14% -$610K ﹤0.01% 3472
2018
Q3
$6.02M Sell
87,994
-17,789
-17% -$1.1M ﹤0.01% 2996
2018
Q2
$5.53M Sell
105,783
-5,727
-5% -$286K ﹤0.01% 3033
2018
Q1
$5.83M Sell
111,510
-250,695
-69% -$13.4M ﹤0.01% 2864
2017
Q4
$17.4M Buy
362,205
+194,013
+115% +$9.61M ﹤0.01% 1792
2017
Q3
$9.25M Buy
168,192
+2,782
+2% +$153K ﹤0.01% 2362
2017
Q2
$9.88M Sell
165,410
-99,479
-38% -$5.59M ﹤0.01% 2203
2017
Q1
$14.6M Sell
264,889
-27,372
-9% -$1.46M ﹤0.01% 1841
2016
Q4
$15.8M Sell
292,261
-60,393
-17% -$2.9M 0.01% 1768
2016
Q3
$15.7M Buy
352,654
+172,885
+96% +$8.41M 0.01% 1637
2016
Q2
$9.3M Buy
179,769
+7,908
+5% +$377K ﹤0.01% 2041
2016
Q1
$7.56M Sell
171,861
-152,000
-47% -$5.99M ﹤0.01% 2116
2015
Q4
$15.3M Buy
323,861
+70,585
+28% +$3.39M 0.01% 1620
2015
Q3
$10.1M Buy
253,276
+80,699
+47% +$3.77M ﹤0.01% 1945
2015
Q2
$7.58M Sell
172,577
-137,744
-44% -$5.71M ﹤0.01% 2387
2015
Q1
$12.3M Buy
310,321
+44,930
+17% +$1.33M ﹤0.01% 1853
2014
Q4
$5.74M Buy
265,391
+160,616
+153% +$3.41M ﹤0.01% 2595
2014
Q3
$1.96M Buy
104,775
+72,609
+226% +$1.56M ﹤0.01% 3451
2014
Q2
$666K Sell
32,166
-930
-3% -$18.9K ﹤0.01% 4371
2014
Q1
$625K Sell
33,096
-165,857
-83% -$3.2M ﹤0.01% 4399
2013
Q4
$3.55M Sell
198,953
-128,825
-39% -$2.23M ﹤0.01% 2902
2013
Q3
$4.33M Buy
327,778
+114,349
+54% +$1.62M ﹤0.01% 2579
2013
Q2
$2.98M Buy
+213,429
New +$2.79M ﹤0.01% 2809

Other funds holding CBM

Morgan Stanley's CBM Position: Q4 2019 in Review

Morgan Stanley sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 128,855 shares — an estimated $7.67M sold.

Morgan Stanley first reported a position in CBM in Q2 2013 and held it in 26 quarters. The position peaked at $17.4M in Q4 2017. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

  • Morgan Stanley reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
  • Morgan Stanley sold 128,855 Cambrex Corporation shares in Q4 2019, an estimated $7.67M.
  • Morgan Stanley first reported a position in Cambrex Corporation in Q2 2013 and held it in 26 quarters.
  • Morgan Stanley's Cambrex Corporation position peaked at $17.4M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.